|
SLFN5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.069610E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.086100E-02 |
| Normal-vs-Stage2 |
9.707400E-01 |
| Normal-vs-Stage3 |
2.575000E-01 |
| Normal-vs-Stage4 |
1.964440E-01 |
| Stage1-vs-Stage2 |
8.131600E-02 |
| Stage1-vs-Stage3 |
6.243800E-01 |
| Stage1-vs-Stage4 |
9.989800E-01 |
| Stage2-vs-Stage3 |
2.771600E-01 |
| Stage2-vs-Stage4 |
2.130600E-01 |
| Stage3-vs-Stage4 |
7.371000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.665900E-02 |
| Normal-vs-AfricanAmerican |
6.494600E-01 |
| Normal-vs-Asian |
9.637800E-01 |
| Caucasian-vs-AfricanAmerican |
4.121400E-01 |
| Caucasian-vs-Asian |
4.099600E-02 |
| AfricanAmerican-vs-Asian |
6.841600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.805400E-01 |
| Normal-vs-Female |
6.939500E-02 |
| Male-vs-Female |
2.745800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.724360E-02 |
| Normal-vs-Age(41-60Yrs) |
5.356600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.653400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.903600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.974450E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.088820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.924400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.128600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.837200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.199600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.142600E-01 |
| Classical-VS-Follicular |
3.75919999573426E-08 |
| Classical-VS-Other |
5.795500E-02 |
| Classical-VS-Normal |
1.092370E-02 |
| Tall-VS-Follicular |
6.999100E-03 |
| Tall-VS-Other |
1.115890E-02 |
| Tall-VS-Normal |
7.003800E-02 |
| Follicular-VS-Other |
4.786000E-01 |
| Follicular-VS-Normal |
1.188390E-01 |
| Other-VS-Normal |
1.959410E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.278400E-01 |
| Normal-vs-N1 |
3.567200E-01 |
| N0-vs-N1 |
6.123000E-01 |
|
|
